- Home
- LINC vs XERS Comparison
LINC vs XERS Comparison
Compare LINC & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LINC
- XERS
- Stock Information
- Founded
- LINC 1946
- XERS 2005
- Country
- LINC United States
- XERS United States
- Employees
- LINC N/A
- XERS N/A
- Industry
- LINC Other Consumer Services
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- LINC Real Estate
- XERS Health Care
- Exchange
- LINC Nasdaq
- XERS Nasdaq
- Market Cap
- LINC 729.2M
- XERS 752.7M
- IPO Year
- LINC 2005
- XERS 2018
- Fundamental
- Price
- LINC $22.87
- XERS $5.09
- Analyst Decision
- LINC Strong Buy
- XERS Strong Buy
- Analyst Count
- LINC 4
- XERS 6
- Target Price
- LINC $24.00
- XERS $6.25
- AVG Volume (30 Days)
- LINC 173.7K
- XERS 1.7M
- Earning Date
- LINC 08-11-2025
- XERS 08-07-2025
- Dividend Yield
- LINC N/A
- XERS N/A
- EPS Growth
- LINC N/A
- XERS N/A
- EPS
- LINC 0.39
- XERS N/A
- Revenue
- LINC $454,204,000.00
- XERS $222,551,000.00
- Revenue This Year
- LINC $13.59
- XERS $35.31
- Revenue Next Year
- LINC $8.08
- XERS $19.65
- P/E Ratio
- LINC $58.44
- XERS N/A
- Revenue Growth
- LINC 15.24
- XERS 29.88
- 52 Week Low
- LINC $11.22
- XERS $2.10
- 52 Week High
- LINC $24.20
- XERS $6.07
- Technical
- Relative Strength Index (RSI)
- LINC 53.65
- XERS 53.59
- Support Level
- LINC $22.23
- XERS $4.94
- Resistance Level
- LINC $22.96
- XERS $5.34
- Average True Range (ATR)
- LINC 0.67
- XERS 0.22
- MACD
- LINC -0.04
- XERS -0.03
- Stochastic Oscillator
- LINC 70.20
- XERS 27.27
About LINC Lincoln Educational Services Corporation
Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include; Campus Operations, and Transitional. The majority of the revenue is generated from the Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).